Inventor · disambiguated record
Seth Porter
Also filed as: PORTER SETH
16 granted patents·10 pending applications·389 citations·filing 1990–2022
95Inventor score
Top patents by PatentIndex Score
26 records- 0198US8987333B2Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Mar 24, 2015·20 cites·11 claims
- 0298US8895617B1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Nov 25, 2014·22 cites·17 claims
- 0398US8895618B1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Nov 25, 2014·22 cites·12 claims
- 0498US8895616B1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Nov 25, 2014·22 cites·14 claims
- 0598US8895615B1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Nov 25, 2014·22 cites·16 claims
- 0698US8895614B2Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Nov 25, 2014·22 cites·11 claims
- 0798US8889740B1Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2014·Granted Nov 18, 2014·21 cites·9 claims
- 0898US8796337B2Composition and method for treating neurological diseaseADAMAS PHARMACEUTICALS INC·Filed 2013·Granted Aug 5, 2014·27 cites·14 claims
- 0998US8389578B2Composition and method for treating neurological diseaseWENT GREGORY T·Filed 2005·Granted Mar 5, 2013·94 cites·8 claims
- 1097US8426472B2Method and composition for administering an NMDA receptor antagonist to a subjectWENT GREGORY T·Filed 2011·Granted Apr 23, 2013·20 cites·10 claims
- 1197US8168209B2Method and composition for administering an NMDA receptor antagonist to a subjectWENT GREGORY T·Filed 2009·Granted May 1, 2012·35 cites·15 claims
- 1285US5260210ABlood-brain barrier modelRUBIN LEE L·Filed 1990·Granted Nov 9, 1993·57 cites·81 claims
- 1379US10039515B2Methods for treating idiopathic pulmonary fibrosisFIBROGEN INC·Filed 2016·Granted Aug 7, 2018·3 cites·5 claims
- 1474US2022151581A1Methods for treating idiopathic pulmonary fibrosisFIBROGEN INC·Filed 2022·Application pending·0 cites
- 1572US9102721B2Therapeutic methodNEFF THOMAS B·Filed 2012·Granted Aug 11, 2015·2 cites·3 claims
- 1672US2013165517A1Composition and Method for Treating Neurological DiseaseADAMAS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1771US2017281565A1Composition for Administering an NMDA Receptor Antagonist to a SubjectADAMAS PHARMA LLC·Filed 2016·Application pending·0 cites
- 1869US10555713B2Methods for treating idiopathic pulmonary fibrosisFIBROGEN INC·Filed 2018·Granted Feb 11, 2020·0 cites·2 claims
- 1967US2014179797A1Composition for Administering an NMDA Receptor Antagonist to a SubjectADAMAS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2064US2017056340A1Composition for Administering an NMDA Receptor Antagonist to a SubjectADAMAS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2163US2019201354A1Composition for administering an nmda receptor antagonist to a subjectADAMAS PHARMA LLC·Filed 2019·Application pending·0 cites
- 2262US9480449B2Methods for treating idiopathic pulmonary fibrosisFIBROGEN INC·Filed 2013·Granted Nov 1, 2016·0 cites·5 claims
- 2362US2020113533A1Methods for treating idiopathic pulmonary fibrosisFIBROGEN INC·Filed 2019·Application pending·0 cites
- 2460US2011059169A1Method and Composition for Administering an NMDA Receptor Antagonist to a SubjectADAMAS PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 2549US2019008799A1Composition for administering an nmda receptor antagonist to a subjectADAMAS PHARMA LLC·Filed 2018·Application pending·0 cites
- 2647US2019127456A1Methods of treating idiopathic pulmonary fibrosisFIBROGEN INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Seth Porter files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →